These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38061470)

  • 1. The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling.
    Xu Q; Zhuo K; Zhang X; Zhen Y; Liu L; Zhang L; Gu Y; Jia H; Chen Q; Liu M; Dong J; Zhou MS
    Eur J Pharmacol; 2024 Jan; 962():176252. PubMed ID: 38061470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice.
    Zhang J; Xu Q; Ren F; Liu Y; Cai R; Yao Y; Zhou MS
    Can J Physiol Pharmacol; 2021 Oct; 99(10):1000-1006. PubMed ID: 33852804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension.
    Xu Q; Zhuo K; Cai R; Su X; Zhang L; Liu Y; Zhu L; Ren F; Zhou MS
    Front Physiol; 2021; 12():732084. PubMed ID: 34650444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
    Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling.
    Wu P; Liu Z; Zhao T; Xia F; Gong L; Zheng Z; Chen Z; Yang T; Duan Q
    Biochem Biophys Res Commun; 2019 May; 512(4):736-741. PubMed ID: 30926167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP/TAZ are Activated by Mechanical and Hormonal Stimuli in Myometrium and Exhibit Increased Baseline Activation in Uterine Fibroids.
    Purdy MP; Ducharme M; Haak AJ; Ravix J; Tan Q; Sicard D; Prakash YS; Tschumperlin DJ; Stewart EA
    Reprod Sci; 2020 Apr; 27(4):1074-1085. PubMed ID: 32056132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
    Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
    J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
    Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
    Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yes-associated protein mediates angiotensin II-induced vascular smooth muscle cell phenotypic modulation and hypertensive vascular remodelling.
    Lin M; Yuan W; Su Z; Lin C; Huang T; Chen Y; Wang J
    Cell Prolif; 2018 Dec; 51(6):e12517. PubMed ID: 30156340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation.
    Garoffolo G; Casaburo M; Amadeo F; Salvi M; Bernava G; Piacentini L; Chimenti I; Zaccagnini G; Milcovich G; Zuccolo E; Agrifoglio M; Ragazzini S; Baasansuren O; Cozzolino C; Chiesa M; Ferrari S; Carbonaro D; Santoro R; Manzoni M; Casalis L; Raucci A; Molinari F; Menicanti L; Pagano F; Ohashi T; Martelli F; Massai D; Colombo GI; Messina E; Morbiducci U; Pesce M
    Circ Res; 2022 Jul; 131(3):239-257. PubMed ID: 35770662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
    Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
    J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
    Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
    Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP/TAZ Are Mechanoregulators of TGF-
    Szeto SG; Narimatsu M; Lu M; He X; Sidiqi AM; Tolosa MF; Chan L; De Freitas K; Bialik JF; Majumder S; Boo S; Hinz B; Dan Q; Advani A; John R; Wrana JL; Kapus A; Yuen DA
    J Am Soc Nephrol; 2016 Oct; 27(10):3117-3128. PubMed ID: 26961347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting YAP/TAZ mechanosignaling to ameliorate stiffness-induced Schlemm's canal cell pathobiology.
    Li H; Kuhn M; Kelly RA; Singh A; Palanivel KK; Salama I; De Ieso ML; Stamer WD; Ganapathy PS; Herberg S
    Am J Physiol Cell Physiol; 2024 Feb; 326(2):C513-C528. PubMed ID: 38105758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
    Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
    EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.
    Dieffenbach PB; Haeger CM; Coronata AMF; Choi KM; Varelas X; Tschumperlin DJ; Fredenburgh LE
    Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L628-L647. PubMed ID: 28642262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts.
    Gao N; Lu L; Ma X; Liu Z; Yang S; Han G
    Exp Dermatol; 2022 Mar; 31(3):320-329. PubMed ID: 34623712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP/TAZ Mediate TGFβ2-Induced Schlemm's Canal Cell Dysfunction.
    Li H; Singh A; Perkumas KM; Stamer WD; Ganapathy PS; Herberg S
    Invest Ophthalmol Vis Sci; 2022 Nov; 63(12):15. PubMed ID: 36350617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical IKB kinases regulate YAP/TAZ and pathological vascular remodeling behaviors in pulmonary artery smooth muscle cells.
    Aravamudhan A; Dieffenbach PB; Choi KM; Link PA; Meridew JA; Haak AJ; Fredenburgh LE; Tschumperlin DJ
    Physiol Rep; 2024 Apr; 12(7):e15999. PubMed ID: 38610069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats.
    Kobayashi N; Nakano S; Mita S; Kobayashi T; Honda T; Tsubokou Y; Matsuoka H
    J Pharmacol Exp Ther; 2002 May; 301(2):459-66. PubMed ID: 11961044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.